Fibrosis

Medical Advocates
HCV Infection/Disease

Liver Fibrosis

HCV Clinical Variants Main New/Newsworthy Home Page

Last Update: March 14, 2011
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader|

Journal Papers, Abstracts, and Commentaries

Biomarkers of fibrosis and impaired liver function in chronic hepatitis C: how well
do they predict clinical outcomes?
Peters L, Rockstroh JK.
Curr Opin HIV AIDS. 2010 Nov;5(6):517-23.
Abstract

Impact of HIV on liver fibrosis in men with hepatitis C infection and haemophilia.
Ragni MV, Moore CG, Soadwa K, et al
Haemophilia. 2010 Aug 16.
Abstract

Low virological response and high relapse rates in hepatitis C genotype 1 patients with
advanced fibrosis despite adequate therapeutic dosing.
Cheng WS, Roberts SK, McCaughan G, et al
J Hepatol. 2010 Jun 16
Abstract

Circulating fibrocytes as a marker of liver fibrosis in chronic hepatitis C.
Nunnari G, Vancheri C, Gilli E, et al
Front Biosci (Elite Ed). 2010 Jun 1;2:1241-5
Abstract

Progression of initially mild hepatic fibrosis in patients with chronic hepatitis C
infection.
Williams MJ, Lang-Lenton M; on behalf of the Trent HCV Study Group
J Viral Hepat. 2010 Jan 18.
Abstract

Risk factors for advanced liver fibrosis in HIV-infected individuals: role of antiretroviral
drugs and insulin resistance.
Blanco F, Barreiro P, Ryan P,.
J Viral Hepat. 2010 Jan 18.
Abstract

Liver stiffness identifies two different patterns of fibrosis progression in patients with
hepatitis C virus recurrence after liver transplantation.
Carrión JA, Torres F, Crespo G, et al
Hepatology. 2009 Oct 18
Abstract

Prediction of significant liver fibrosis in kidney transplant patients with chronic
hepatitis C virus infection: the TX-3 index.
Schiavon LL, Carvalho-Filho RJ, Narciso-Schiavon JL, et al
J Viral Hepat. 2009 Sep 15
Abstract

Influence of insulin resistance on Hepatic Fibrosis and Steatosis in HCV Monoinfected
compared with HIV-HCV
co-infected patients.
Halfon P, Pénaranda G, Carrat F, et al
Aliment Pharmacol Ther. 2009 Mar 9.
Abstract

Serum Fibrosis Marker Levels Decrease After Successful Antiviral Treatment in Chronic Hepatitis C
Patients With Advanced Fibrosis.
Fontana RJ, Bonkovsky HL, Naishadham D, et al
Clin Gastroenterol Hepatol. 2008 Nov
Abstract

The Impact of Diet on Liver Fibrosis and on Response to Interferon Therapy in Patients With
HCV-Related Chronic Hepatitis
Loguercio C, Federico A, Masarone M,et al
Am J Gastroenterol. 2008 Sep 11
Abstract

Incidence and Predictors of Severe Liver Fibrosis in HIV-Infected Patients with Chronic
Hepatitis C in Brazil.
Mendes-Correa MC, Widman A, Brussi ML, et al
AIDS Patient Care STDS. 2008 Aug 28.
Abstract

Diagnostic accuracy, reproducibility and robustness of fibrosis blood tests in chronic hepatitis C:
A meta-analysis with individual data.
Leroy V, Halfon P, Bacq Y, et al
Clin Biochem. 2008 Jul 11
Abstract

Effect of steatosis and inflammation on liver fibrosis in chronic hepatitis C.
Nieminen U, Arkkila PE, Kärkkäinen P, Färkkilä MA.
Liver Int. 2008 May 14.
Abstract

Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in
patients with advanced chronic hepatitis C.
Fontana RJ, Goodman ZD, Dienstag JL,et al
Hepatology. 2008 Jan 3
Abstract

FULL TEXT PDF ARTICLE
Estimating past hepatitis C infection risk from reported risk factor histories: implications for
imputing age of infection and modeling fibrosis progression.
Bacchetti P, Tien PC, Seaberg EC, et al
BMC Infect Dis. 2007 Dec 10;7(1):145
Paper

Increased levels of galactose-deficient anti-gal IgG in the sera of HCV infected individuals
with fibrosis and cirrhosis.
Mehta AS, Long RE, Comunale MA, et al
J Virol. 2007 Nov 28
Abstract

Connective tissue growth factor, steatosis and fibrosis in patients with chronic hepatitis C.
Hora C, Negro F, Leandro G, et al
Liver Int. 2007 Nov 1;
Abstract

FULL TEXT ARTICLE
Chronic hepatitis C and fibrosis: evidences for possible estrogen benefits.
Codes L, Matos L, Paraná R.
Braz J Infect Dis. 2007 Jun;11(3):371-4.
Paper

Liver Fibrosis Is Associated with Decreased Peripheral Platelet Count in Patients with
Chronic Hepatitis B and C.
Karasu Z, Tekin F, Ersoz G, et al
Dig Dis Sci. 2007 Apr 27
Abstract

A multivariable model of clinical variables predicts advanced fibrosis in chronic hepatitis C.
Alsatie M, Kwo PY, Gingerich JR, et al
J Clin Gastroenterol. 2007 Apr;41(4):416-21
Abstract

The endocannabinoid system as a novel target for the treatment of liver fibrosis.
Teixeira-Clerc F, Julien B, Grenard P, et al
Pathol Biol (Paris). 2007 Apr 3;
Abstract

Post-load insulin resistance is an independent predictor of hepatic fibrosis in Virus C
Chronic Hepatitis and in Nonalcoholic Fatty Liver Disease.
Svegliati-Baroni G, Bugianesi E, Bousheral T, et al
Gut. 2007 Mar 28
Abstract

The natural history of hepatitis C with severe hepatic fibrosis.
Lawson A, Hagan S, Rye K, et al
J Hepatol. 2007 Mar 7;
Abstract

Risk factors for hepatitis C fibrosis: a prospective study of United States veterans* compared
with nonveterans.
Kayali Z, Tan S, Shinkunas L, et al
J Viral Hepat. 2007 Jan;14(1):11-21.
Abstract

The impact of diabetes mellitus on fibrosis progression in patients transplanted for hepatitis C.
Foxton MR, Quaglia A, Muiesan P, et al
Am J Transplant. 2006 Aug;6(8):1922-9.
Abstract

Contributions to Hepatic Fibrosis in HIV-HCV Coinfected and HCV Monoinfected Patients.
Monto A, Kakar S, Dove LM, et al
Am J Gastroenterol. 2006 Jul;101(7):1509-15.
Abstract

Progression of liver fibrosis among injection drug users with chronic hepatitis C.
Wilson LE, Torbenson M, Astemborski J, et a;
Hepatology. 2006 Mar 23;43(4):788-795
Abstract

FULL-TEXT ARTICLE
Correlation between ultrasonographic and pathologic diagnosis of liver fibrosis due to chronic
virus hepatitis.
Shen L, Li JQ, Zeng MD, et al
World J Gastroenterol. 2006 Feb 28;12(8):1292-5.
Abstract

Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for
the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca
study.
Halfon P, Bourliere M, Deydier R
Am J Gastroenterol. 2006 Mar;101(3):547-55.
Abstract

Predictors of Liver Fibrosis in HIV-Infected Patients with Chronic Hepatitis C Virus (HCV) Infection:
Assessment Using Transient Elastometry and the Role of HCV Genotype 3.
Barreiro P, Martin-Carbonero L, Nunez M , et al
Clin Infect Dis. 2006 Apr 1;42(7):1032-9.
Abstract

FULL-TEXT ARTICLE
Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis
in patients with non-alcoholic fatty liver disease.
Ratziu V, Massard J, Charlotte F, et al
BMC Gastroenterol. 2006 Feb 14;6:6.
Paper

Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in
chronic hepatitis C.
Sebastiani G, Vario A, Guido M, et ak
J Hepatol. 2006 Feb 8;
Abstract

Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C.
Hezode C, Roudot-Thoraval F, Nguyen S, et al
Hepatology. 2005 May 12;
Abstract

Investigation of liver fibrosis in clinical practice.
Blanc JF, Bioulac-Sage P, Balabaud C, et al
Hepatol Res. 2005 Apr 27;
Abstract

Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance
in a probability index.
Sud A, Hui JM, Farrell GC, Bandara P, et al
Hepatology. 2004 May;39(5):1239-47.
Abstract

Liver fibrosis in chronic viral hepatitis: An ultrasonographic study.
Zheng RQ, Wang QH, Lu MD, et al
World J Gastroenterol. 2003 Nov;9(11):248
Abstract

	Influence factors of serum fibrosis markers in liver fibrosis. Tao J, Peng HQ, Cai WM, et al World J Gastroenterol. 2003 Nov;9(11):2497-500 Abstract
	Non-invasive detection of liver fibrosis: Is superparamagnetic iron oxide particle-enhanced MR imaging a contributive technique? Lucidarme O, Baleston F, Cadi M, et al. Eur Radiol 2003 Mar;13(3):467-74 Abstract

HCV Clinical Variants

Main New/Newsworthy

Home Page

HCV Liver Fibrosis

Medical Advocates HCV Infection/Disease
		Liver Fibrosis